Sector Gamma AS’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Sector Gamma AS's TVTX Position: Q3 2026 in Review
Sector Gamma AS reduced its Travere Therapeutics (TVTX) stake by 15% in Q3 2026, selling an estimated $733K and leaving 68,000 shares worth $4M. The position accounts for 0.83% of the portfolio, ranked #36.
Sector Gamma AS first reported a position in TVTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $4.54M in Q2 2026. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Sector Gamma AS held 68,000 shares of Travere Therapeutics worth $4M as of Q3 2026.
- Sector Gamma AS sold 12,000 Travere Therapeutics shares in Q3 2026, an estimated $733K.
- Travere Therapeutics made up 0.83% of Sector Gamma AS's portfolio in Q3 2026, its #36 holding.
- Sector Gamma AS first reported a position in Travere Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Sector Gamma AS's Travere Therapeutics position peaked at $4.54M in Q2 2026.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Sector Gamma AS's 13F filing for Q3 2026, filed 12 Nov 2026.